Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Tissue engineering ex vivo and direct cellular application with bioscaffolds in vivo has allowed surgeons to restore and establish function throughout the human body. The evidence for regenerative surgery is growing, and consequently there is a need for the development of more advanced regenerative surgery facilities. Regenerative medicine in the surgical field is changing rapidly and this must be reflected in the design of any future operating suite. The theater environment needs to be highly adaptable to account for future significant advances within the field. Development of purpose built, combined operating suites and tissue-engineering laboratories will provide the facility for modern surgeons to treat patients with organ deficits, using bespoke, regenerated constructs without the need for immunosuppression.

Original publication

DOI

10.2217/rme.14.46

Type

Journal article

Journal

Regenerative medicine

Publication Date

01/2014

Volume

9

Pages

785 - 791

Addresses

UCL Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK.

Keywords

Stem Cells, Humans, Stem Cell Transplantation, Tissue Engineering, Artificial Organs, Specialties, Surgical, Regenerative Medicine, Tissue Scaffolds